| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |